Compound Profile: WINSTROL AMP IMPERIA
Winstrol AMP Imperia represents a standardised stanozolol preparation designed for sophisticated laboratory investigations into anabolic-androgenic steroid mechanisms. Stanozolol is a synthetic derivative of dihydrotestosterone, exhibiting unique structural modifications that create distinct androgenic receptor binding characteristics in experimental models. Researchers at Stroid UK Shop utilise this compound to investigate protein synthesis pathways, nitrogen retention mechanisms, and cellular metabolic processes under controlled laboratory conditions.
Laboratory Applications
This preparation enables comprehensive research into stanozolol’s molecular interactions with androgen receptors, particularly its tissue-selective properties that distinguish it from testosterone derivatives. Scientists examine its effects on collagen synthesis modulation, hepatic metabolism pathways, and lipid profile alterations in experimental models. The compound serves as a valuable reference standard for comparative studies with other stanozolol preparations, enabling researchers to evaluate bioavailability, receptor binding affinity, and metabolic conversion rates. Advanced investigations focus on stanozolol’s unique ability to enhance protein synthesis while potentially reducing sex hormone-binding globulin levels in laboratory settings. Comparative studies with selective androgen receptor modulators and research peptides provide valuable insights into tissue-specific androgenic activity mechanisms.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Stanozolol |
| CAS Number | 10418-03-8 |
| Molecular Formula | C₂₁H₃₂N₂O |
| Molecular Weight | 328.49 g/mol |
| Form | Ampoule preparation |
| Storage | Room temperature, dry conditions |
Research Compliance
This product is manufactured by Imperia exclusively for in-vitro laboratory research applications. Not intended for human consumption, therapeutic use, or any purpose other than qualified scientific investigation. Researchers must ensure appropriate laboratory safety protocols and regulatory compliance when conducting stanozolol-related studies.
